At a glance

ClinicalIndex Comparison Record

N/ACompleted· 64 enrolled

Drug / intervention

Piiloset Trehalose Emulsion Eye Drops +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03569202

NCT03569202N/ACompleted

Compare CT.gov

A Randomized, Active-controlled, Parallel, Double-blind Study on the Safety, Ocular Tolerability and Efficacy of Piiloset Trehalose Emulsion Eye Drop in Adult Patients With Moderate or Severe Dry Eye

Kuopio University Hospital·interventional·Posted Jun 26, 2018·Updated Dec 13, 2019

In Brief

A clinical study evaluating Piiloset Trehalose Emulsion Eye Drops and Control Eye Drops for Dry Eye Syndrome. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The study evaluates the safety, ocular tolerability and efficacy of emulsion eye drops with sacha inchi seed oil, trehalose and hyaluronic acid in the treatment of moderate or severe dry eye in adult patients. The investigative device is studied in comparison with control eye drops containing hyaluronic acid for up to 30 days.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDry Eye Syndrome

CountriesFinland

CollaboratorsFinnsusp Ltd., 4Pharma Ltd., Business Finland

Timeline

N/ACompletedFinished

20192020202120222023202420252026

Enrollment StartMay 2018

First PostedJun 2018

Primary CompletionNov 2018

TodayJul 2026

First PostedJun 26, 2018

Enrollment StartMay 21, 2018

Primary CompletionNov 8, 2018

TodayJul 2, 2026

Enrollment to primary: 6 monthsPosted 8.0 years ago

Interventions

Piiloset Trehalose Emulsion Eye Dropsdevice

Topical application of preservative-free multidose Piiloset Trehalose Emulsion Eye Drops 3 times daily

Control Eye Dropsdevice

Topical application of preservative-free multidose Hyaluronic Acid Eye Drops 3 times daily